+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Partial Seizure - Pipeline Insight, 2024 - Product Thumbnail Image

Partial Seizure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Partial Epilepsy - Pipeline Insight, 2024 - Product Thumbnail Image

Partial Epilepsy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Parkinson's disease - Pipeline Insight, 2024 - Product Thumbnail Image

Parkinson's disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
Myasthenia Gravis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Myasthenia Gravis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • April 2024
  • 287 Pages
  • Global
From
Refractory Epilepsy - Pipeline Insight, 2024 - Product Thumbnail Image

Refractory Epilepsy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Antibody Drug Conjugate - Competitive Landscape, 2025 - Product Thumbnail Image

Antibody Drug Conjugate - Competitive Landscape, 2025

  • Report
  • March 2025
  • 450 Pages
  • Global
From
Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis (ALS) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 267 Pages
  • Global
From
Epilepsy - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Epilepsy - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 395 Pages
  • Global
From
Tonic-Clonic Seizures Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Tonic-Clonic Seizures Treatment Market Report and Forecast 2024-2032

  • Report
  • October 2024
  • 250 Pages
  • Global
From
TNF Alpha Inhibitors Global Market Report 2024 - Product Thumbnail Image

TNF Alpha Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Blood Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Blood Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Neonatal Fc receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Neonatal Fc receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Complement C5 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Complement C5 inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Systemic Lupus Erythematosus and Lupus Nephritis: Global Drug Forecast and Market Analysis to 2027 - Product Thumbnail Image

Systemic Lupus Erythematosus and Lupus Nephritis: Global Drug Forecast and Market Analysis to 2027

  • Report
  • February 2020
  • 163 Pages
  • Global
From
PI3K inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

PI3K inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
Acute Repetitive Seizures Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, & Forecast 2023-2030 - (By Drug Type Coverage, Route of Administration Coverage, Distribution Channel Coverage, End-use Coverage, Geographic Coverage & Leading Companies) - Product Thumbnail Image

Acute Repetitive Seizures Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, & Forecast 2023-2030 - (By Drug Type Coverage, Route of Administration Coverage, Distribution Channel Coverage, End-use Coverage, Geographic Coverage & Leading Companies)

  • Report
  • October 2023
  • 240 Pages
  • Global
Intractable Focal Epilepsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Intractable Focal Epilepsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • August 2023
  • 220 Pages
  • Global
Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • January 2024
  • 595 Pages
  • Global
From
Anti-Epileptic Drugs Market: Analysis By Drug Generation, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 - Product Thumbnail Image

Anti-Epileptic Drugs Market: Analysis By Drug Generation, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028

  • Report
  • October 2023
  • 159 Pages
  • Global
From
Drug Resistant Epilepsy - Pipeline Insight, 2024 - Product Thumbnail Image

Drug Resistant Epilepsy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Loading Indicator